ORGO News and Press, Organogenesis Holdings Inc. From 02/04/22

The recent market pullback was arguably overdue and is already making stocks attractive for longer-term investors. Insiders are giving excellent industry signals to act on and numerous specific stocks to consider. Take your pick of insider-approved energy, bank, income, infrastruc...

Radnor, Pennsylvania--(Newsfile Corp. - January 24, 2022) -  The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action c...

Pharma/biotech is the most attractive subsector. The most overvalued one is life science tools. IXJ: an alternative to XLV. 10 stocks cheaper than their peers in December. For further details see: IXJ: Healthcare Dashboard For December

NEW YORK, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO) in the United States District Court for the Easter...

CANTON, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...

New York, New York--(Newsfile Corp. - November 14, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Organogenesis ("Organogenesis Holdings Inc." or the "Company") (NASDAQ: ORGO). If you suffered losses exceeding $50,000 inves...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Organogenesis To Contact Him Directly To Discuss Their Options NEW YORK - ( NewMediaWire ) - November 12, 2021 - Faruqi & Faruqi, LLP, a leading national securities law fi...

Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO) Q3 2021 Earnings Call Nov 09, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis Holdings Inc (ORGO) Q3 2021 Earnings Call Transcri...

Organogenesis Holdings Inc. (ORGO) Q3 2021 Results Conference Call November 09, 2021 05:00 PM ET Company Participants Gary Gillheeney - President and Chief Executive Officer David Francisco - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Matt Miksic - Credit Suiss...

CANTON, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...